tiprankstipranks
Trending News
More News >
Ajanta Pharma Limited (IN:AJANTPHARM)
:AJANTPHARM
India Market

Ajanta Pharma Limited (AJANTPHARM) Financial Statements

Compare
3 Followers

Ajanta Pharma Limited Financial Overview

Ajanta Pharma Limited's market cap is currently ₹315.40B. The company's EPS TTM is ₹18; its P/E ratio is 34.33; and it has a dividend yield of 2.14%. Ajanta Pharma Limited is scheduled to report earnings on April 30, 2025, and the estimated EPS forecast is ₹20.70. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 46.48B₹ 42.09B₹ 37.43B₹ 32.84B₹ 28.47B
Gross Profit₹ 35.77B₹ 30.93B₹ 26.92B₹ 23.97B₹ 21.65B
Operating Income₹ 22.64B₹ 19.68B₹ 6.62B₹ 8.08B₹ 8.90B
EBITDA₹ 12.68B₹ 12.57B₹ 8.81B₹ 10.44B₹ 10.24B
Net Income₹ 9.20B₹ 8.16B₹ 5.88B₹ 7.13B₹ 6.54B
Balance Sheet
Cash & Short-Term Investments₹ 6.15B₹ 4.60B₹ 8.44B₹ 3.28B₹ 3.78B
Total Assets₹ 50.15B₹ 46.38B₹ 46.79B₹ 40.56B₹ 37.79B
Total Debt₹ 474.20M₹ 352.80M₹ 356.30M₹ 250.30M₹ 313.60M
Net Debt₹ -1.29B₹ -942.10M₹ -2.94B₹ -1.81B₹ -1.46B
Total Liabilities₹ 12.25B₹ 10.71B₹ 12.91B₹ 7.91B₹ 7.83B
Stockholders' Equity₹ 37.90B₹ 35.67B₹ 33.88B₹ 32.64B₹ 29.96B
Cash Flow
Free Cash Flow₹ 8.39B₹ 6.33B₹ 6.17B₹ 4.13B₹ 4.05B
Operating Cash Flow₹ 11.57B₹ 7.85B₹ 7.92B₹ 5.62B₹ 5.76B
Investing Cash Flow₹ -3.77B₹ 653.90M₹ -5.60B₹ -741.00M₹ -2.82B
Financing Cash Flow₹ -7.33B₹ -10.51B₹ -1.08B₹ -4.60B₹ -3.18B
Currency in INR

Ajanta Pharma Limited Earnings and Revenue History

Ajanta Pharma Limited Debt to Assets

Ajanta Pharma Limited Cash Flow

Ajanta Pharma Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis